Condition: NASH · Sponsor: Tasly Pharmaceutical Group Co., Ltd
This study will evaluate the efficacy and safety and the best effective dose of HuHuangLianzonggan capsule in subjects with nonalcoholic steatohepatitis.
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| Anhui Provincial Hospital | Hefei, Anhui, China | Not Yet Recruiting |
| The Second Hospital of Anhui Medical University | Hefei, Anhui, China | Not Yet Recruiting |
| Peking University Third Hospital | Beijing, Beijing Municipality, China | Recruiting |
| The first affiliated hospital of Fujian medical university | Fuzhou, Fujian, China | Not Yet Recruiting |
| Nanfang Hospital, Southern Medical University | Guangzhou, Guangdong, China | Not Yet Recruiting |
| The Third People's Hospital of Shenzhen | Shenzhen, Guangdong, China | Recruiting |
| The First Affiliated Hospital of Henan University of Science and Technology | Luoyang, Henan, China | Recruiting |
| Union Hospital Tongji Medical College Huazhong University of Science and Technology | Wuhan, Hubei, China | Recruiting |
| The First People's Hospital of Lianyungang | Lianyungang, Jiangsu, China | Recruiting |
| The Affiliated Hospital of Nanjing University medical school,Nanjing Drum Tower Hospital | Nanjing, Jiangsu, China | Not Yet Recruiting |
| The Second Hospital of Nanjing | Nanjing, Jiangsu, China | Recruiting |
| The Affiliated Hospital of Xuzhou Medical University | Xuzhou, Jiangsu, China | Recruiting |
+ 8 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05632861